Related Experiment Videos
Beta1-adrenoceptor gene variations: a role in idiopathic dilated cardiomyopathy?
S Podlowski1, K Wenzel, H P Luther
1Max Delbrück Center for Molecular Medicine, Berlin-Buch, Germany.
Insights
Genetic variations in the human beta1-adrenoceptor (beta1-AR) gene are linked to dilated cardiomyopathy (DCM). The Ser-49-Gly mutation was more frequent in idiopathic DCM patients, suggesting a role in heart disease.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
Background:
- Dilated cardiomyopathy (DCM) is a severe heart disease with significant public health implications.
- Evidence suggests the human beta1-adrenoceptor (beta1-AR) gene plays a role in DCM pathophysiology.
- Beta1-AR signal transduction is altered in DCM due to downregulation, impairing myocardial response.
Purpose of the Study:
- To investigate genetic variations in the beta1-AR gene as a candidate for idiopathic dilated cardiomyopathy (IDCM).
- To analyze the association of specific beta1-AR gene polymorphisms with IDCM in selected patients and controls.
Main Methods:
- Analysis of 18 single nucleotide polymorphisms (SNPs) in the beta1-AR gene.
- Identification of 7 amino acid exchanges resulting from these SNPs.
- Genotyping of patients with IDCM and control individuals.
Main Results:
- 17 SNPs were located in the N-terminal and C-terminal regions of the coding exon.
- Seven amino acid exchanges were identified: Ser-49-Gly, Ala-59-Ser, Gly-389-Arg, Arg-399-Cys, His-402-Arg, Thr-404-Ala, and Pro-418-Ala.
- Genotypes with the Ser-49-Gly mutation (heterozygous or homozygous) were significantly more frequent in IDCM patients.
Conclusions:
- The study provides potential insights into the molecular mechanisms underlying IDCM.
- The findings suggest a specific role for beta1-AR genetic variations, particularly the Ser-49-Gly mutation, in the development of IDCM.
- This research contributes to understanding the nature, distribution, and evolutionary aspects of sequence variation in human adrenergic receptor genes.
Abstract:
A substantial body of evidence suggests involvement of the human beta1-adrenoceptor (beta1-AR) gene in the pathophysiology of dilated cardiomyopathy (DCM), a severe heart disease of significant public health impact. Beta1-AR-mediated signal transduction is dramatically altered due to downregulation, resulting in an impairment of myocardial response. The important role of genetic factors in idiopathic dilated cardiomyopathy (IDCM) recently recognized, we analyzed this prime candidate gene for genetic variation in carefully selected patients and controls. In this preliminary study, 18 single nucleotide polymorphisms were observed, 17 of which were located in the N-terminal and C-terminal region of the coding exon, resulting in 7 amino acid exchanges: Ser-49-Gly, Ala-59-Ser, Gly-389-Arg, Arg-399-Cys, His-402-Arg, Thr-404-Ala, and Pro-418-Ala. These mutations resulted in 11 different beta1-AR genotypes. Importantly, the genotypes carrying the Ser-49-Gly mutation in the N-terminus of the molecule in a heterozygous or homozygous form were observed significantly more frequently in the group of IDCM patients. The present results may provide a clue on the molecular mechanisms involved in IDCM, and add moreover interesting information on nature, distribution, and evolutionary aspects of sequence variation in human adrenergic receptor genes.